Prediction of recurrence with the Oncotype DX recurrence score in node-positive, HR-positive, breast cancer patients treated with adjuvant chemotherapy: Results from PACS01 trial.

被引：4
|
作者：
Penault-Llorca, Frederique Madeleine
Filleron, Thomas
Asselain, Bernard
Baehner, Frederick L.
Fumoleau, Pierre
Lacroix-Triki, Magali
Butler, Steven M.
Jamshidian, Farid
Cherbavaz, Diana B.
Shak, Steven
Roca, Lise
Sagan, Christine
Lemonnier, J.
Martin, Anne-Laure
Roche, Henri Hubert
机构：
[1] Ctr Jean Perrin, Clermont Ferrand, France
[2] Inst Claudius Regaud, Toulouse, France
[3] Curie Site Paris, Paris, France
[4] Genom Hlth Inc, Redwood City, CA USA
[5] Ctr Georges Francois Leclerc, Dijon, France
[6] Inst Reg Canc Montpellier Val dAurelle, Montpellier, France
[7] Inst Cancerol Ouest Site Rene Gauducheau, St Herblain, France
[8] R&D UNICANC, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.11052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11052
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A
  • [2] Utilizing the Oncotype DX Recurrence Score in the Adjuvant Treatment Management of Node-Positive, Early-Stage Breast Cancer Patients
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
  • [3] Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database
    Roberts, Megan
    Petkov, Valentina I.
    Miller, Dave P.
    Shak, Steven
    Howlader, Nadia
    Cronin, Kathleen
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Cost-effectiveness of the Oncotype DX Breast Recurrence Score test in postmenopausal women with node-positive early breast cancer based on the RxPONDER trial.
    Berdunov, Vladislav
    Millen, Steve
    Paramore, Andrew
    Reynia, Sarah
    Fryer, Nina
    Griffin, Jane
    Georges, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer
    Berdunov, Vladislav
    Millen, Steve
    Paramore, Andrew
    Hall, Peter
    Perren, Timothy
    Brown, Rebecca
    Griffin, Jane
    Reynia, Sarah
    Fryer, Nina
    Longworth, Louise
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 591 - 604
  • [6] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Megan C. Roberts
    Dave P. Miller
    Steven Shak
    Valentina I. Petkov
    Breast Cancer Research and Treatment, 2017, 163 : 303 - 310
  • [7] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Roberts, Megan C.
    Miller, Dave P.
    Shak, Steven
    Petkov, Valentina I.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 303 - 310
  • [8] Impact of Oncotype DX Recurrence Score on Adjuvant Chemotherapy Recommendations in Young Patients with Breast Cancer
    Dodman, Keisha G.
    Williams, Austin D.
    De La Cruz, Lucy M.
    Tchou, Julia C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E6 - E6
  • [9] Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients:: The FNCLCC PACS 01 trial
    Roche, Henri
    Fumoleau, Pierre
    Spielmann, Marc
    Canon, Jean-Luc
    Delozier, Thierry
    Serin, Daniel
    Symann, Michel
    Kerbrat, Pierre
    Soulie, Patrick
    Eichler, Francoise
    Viens, Patrice
    Monnier, Alain
    Vindevoghel, Anita
    Campone, Mario
    Goudier, Marie-Josephe
    Bonneterre, Jacques
    Ferrero, Jean-Marc
    Martin, Anne-Laure
    Geneve, Jean
    Asselain, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5664 - 5671
  • [10] Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial
    Jacquemier, Jocelyne
    Boher, Jean-Marie
    Roche, Henri
    Esterni, Benjamin
    Serin, Daniel
    Kerbrat, Pierre
    Andre, Fabrice
    Finetti, Pascal
    Charafe-Jauffret, Emmanuelle
    Martin, Anne-Laure
    Campone, Mario
    Viens, Patrice
    Birnbaum, Daniel
    Penault-Llorca, Frederique
    Bertucci, Francois
    BREAST CANCER RESEARCH, 2011, 13 (06):
12345